ConductScience.org, home

Paper20173543

T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.

Kano H and 5 others. Neurosurgery, 2010. Cited by 155 papers, by iCite.

Cite this record

ConductScience Library. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Papers, record 20173543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20173543

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.
PubMed
Journal
Neurosurgery
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
155
iCite
Relative citation ratio, by iCite
5.25
iCite
Revised in PubMed
2010-02-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kano HHideyuki
2Kondziolka DDouglas
3Lobato-Polo JJavier
4Zorro OOscar
5Flickinger JCJohn C
6Lunsford LDL Dade

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasm Recurrence, LocalMajor topic
Neurosurgical ProceduresMajor topic
RadiosurgeryMajor topic
Adult
Aged
Aged, 80 and over
Brain Neoplasms
Disease Progression
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Statistics, Nonparametric
Young Adult

Source PubMed

Download CSV of topics

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.

PMIDTitleJournalYearIn PapersSource
42663779Pathology-validated structural and physiologic habitat imaging for differentiating radiation necrosis from tumor recurrence in brain metastases.J Neurooncol2026https://conductscience.org/library/papers/42663779PubMed
42585297LINAC-based single-isocenter stereotactic radiotherapy for multiple brain metastases.J Radiat Res2026https://conductscience.org/library/papers/42585297PubMed
42484747The threefold value of surgery in previously irradiated brain metastases.J Neurooncol2026https://conductscience.org/library/papers/42484747PubMed
42029788Long-term safety and efficacy of staged stereotactic radiosurgery with Ommaya reservoir aspiration for large cystic brain metastases.J Neurooncol2026https://conductscience.org/library/papers/42029788PubMed
41949945Optimising Brain Metastases Management in Resource-Limited Settings: Experience with Hypofractionated Stereotactic Radiotherapy at the Salah Azaiez Institute.Tunis Med2025https://conductscience.org/library/papers/41949945PubMed
41266380MU-Glioma Post: A comprehensive dataset of automated MR multi-sequence segmentation and clinical features.Sci Data2025https://conductscience.org/library/papers/41266380PubMed
40913628FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principle.Clin Exp Metastasis2025https://conductscience.org/library/papers/40913628PubMed
40839242Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment.J Neurooncol2025https://conductscience.org/library/papers/40839242PubMed
40702846The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease.Cancer Sci2025https://conductscience.org/library/papers/40702846PubMed
40560014Applications of Advanced Imaging for Radiotherapy Planning and Response Assessment in the Central Nervous System.Tomography2025https://conductscience.org/library/papers/40560014PubMed
39961102Re-irradiation followed by resection for recurrent brain metastases after initial stereotactic radiosurgery: illustrative cases.J Neurosurg Case Lessons2025https://conductscience.org/library/papers/39961102PubMed
39677170Magnetic Resonance Imaging Assessment of Morphological Changes and Molecular Behavior to Evaluate Treatment Response of Brain Metastatic Lesions After Stereotactic Radiosurgery.Cureus2024https://conductscience.org/library/papers/39677170PubMed
39193387Single versus multiple fraction stereotactic radiosurgery for medium-sized brain metastases (4-14 cc in volume): reducing or fractionating the radiosurgery dose?Front Oncol2024https://conductscience.org/library/papers/39193387PubMed
39107039Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases.AJNR Am J Neuroradiol2025https://conductscience.org/library/papers/39107039PubMed
39026289Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM).BMC Cancer2024https://conductscience.org/library/papers/39026289PubMed
38730695Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis.Cancers (Basel)2024https://conductscience.org/library/papers/38730695PubMed
38707120
Proposal of an Alternative Near-Minimum Isodose Surface DV-0.01 cc Equally Minimizing Gross Tumor Volume Below the Relevant Dose as the Basis for Dose Prescription and Evaluation of Stereotactic Radiosurgery for Brain Metastases.
Cureus2024https://conductscience.org/library/papers/38707120PubMed
38630386Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.J Neurooncol2024https://conductscience.org/library/papers/38630386PubMed
38437665The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.Neuro Oncol2024https://conductscience.org/library/papers/38437665PubMed
38356008Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.Ann Nucl Med2024https://conductscience.org/library/papers/38356008PubMed

See all 84 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20173543

GET https://conductscience.org/api/papers/v1/20173543/cited_by?page=2